If you need more lookups,
subscriptions start at $34 USD/month.
Mark Field Location
United Kingdom
Mark Field Work
CEO and Co-Founder @ (October 2020 - Present)
Visiting Lecturer - Institute of Psychiatry, Psychology and Neuroscience @ (February 2020 - Present)
Head Pain R and D- Senior Vice President @ (May 2015 - June 2019)
Senior Vice President - Head of Global Early Clinical Development @ (June 2010 - April 2015)
Director of CNS Experimental Medicine @ (July 2009 - June 2010)
Clinical Lead - Director @ (September 2003 - May 2009)
Head of in vivo Pharmacology - Pain @ (January 2000 - September 2003)
Senior Group Leader - Preclinical Project Lead @ (January 1990 - January 2000)
Researcher @ (January 1986 - January 1990)
Mark Field Education
King's College London
(Neuroscience)
University of Portsmouth
Doctor of Philosophy (Philosophy, Pharmacy)
Insead
(Leadership)
Mark Field Skills
Clinical Development
Neuroscience
Translational Medicine
Clinical Trials
Pharmacology
Clinical Research
Neurology
Pain Management
Pharmaceutical Industry
Drug Development
Drug Discovery
In Vivo
Biotechnology
Biomarkers
Lifesciences
R&D
Biopharmaceuticals
GLP
Clinical Pharmacology
IND
Informatics
CRO
Therapeutic Areas
Medical Affairs
Medicine
Inflammation
GCP
Immunology
CTMS
Regulatory Submissions
Regulatory Affairs
PK/PD
Diabetes
Pharmacokinetics
Medical Writing
Phase I
Psychiatry
Life Sciences
Development
Communications
Research and Development R&d
Research
Research and Development
Mark Field Summary
Mark Field, based in United Kingdom, is currently a CEO and Co-Founder at eptivA Therapeutics Ltd.. Mark Field brings experience from previous roles at King's College London, Grünenthal Group and UCB Pharma. Mark Field holds a King's College London. With a robust skill set that includes Clinical Development, Neuroscience, Translational Medicine, Clinical Trials, Pharmacology and more. Mark Field has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Field?
Find contact details for 700 million professionals.